Results 181 to 190 of about 23,301 (197)

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes

Annals of Oncology, 2015
Dai Chihara, Richard Champlin, John Seymour   +2 more
exaly  

Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?

Annals of Oncology, 2002
Fernando Cabanillas, Issa Khouri, Jorge Romaguera   +2 more
exaly  

Management of mantle cell lymphoma

Annals of Hematology, 1999
P, Meusers, J, Hense
openaire   +2 more sources

Central nervous system involvement in mantle cell lymphoma

Annals of Oncology, 2008
Francesc Bosch
exaly  

Observation as the initial management strategy in patients with mantle cell lymphoma

Annals of Oncology, 2017
Randy Gascoyne, Diego Villa, J M Connors   +2 more
exaly  

Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study

Annals of Oncology, 2002
, Yukio Kobayashi, Y Matsuno
exaly  

Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms

Modern Pathology, 2009
Juehua Gao, Yi-Hua Chen, Guang Fan
exaly  

Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma

Journal of Experimental Medicine, 2008
Markus Welcker, Bailey Alexis S, Fleming William H   +2 more
exaly  

Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma

Annals of Oncology, 2010
Andrew D Zelenetz, C H Moskowitz, C S Portlock   +2 more
exaly  

Incidence of preclinical manifestations of mantle cell lymphoma and mantle cell lymphoma in situ in reactive lymphoid tissues

Modern Pathology, 2012
Leticia Quintanilla-Martinez, Falko Fend, Ana-Iris Schiefer   +2 more
exaly